Peer Review reports
From: Response to pembrolizumab in a patient with primary lung adenocarcinoma originated from indium lung
| Original Submission | ||
|---|---|---|
| 20 Oct 2020 | Submitted | Original manuscript |
| 13 Dec 2020 | Reviewed | Reviewer Report |
| 14 Dec 2020 | Reviewed | Reviewer Report |
| 23 Dec 2020 | Author responded | Author comments - Yasuharu Sekine |
| Resubmission - Version 2 | ||
| 23 Dec 2020 | Submitted | Manuscript version 2 |
| Publishing | ||
| 22 Mar 2021 | Editorially accepted | |
| 31 Mar 2021 | Article published | 10.1186/s12890-021-01474-x |
You can find further information about peer review here.